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Cyclic lipodepsipeptides produced by Pseudomonas spp. (Ps-CLPs) are biosurfactants
that constitute a diverse class of versatile bioactive natural compounds with promising
application potential. While chemically diverse, they obey a common structural
blue-print, allowing the definition of 14 distinct groups with multiple structurally
homologous members. In addition to antibacterial and antifungal properties the reported
activity profile of Ps-CLPs includes their effect on bacterial motility, biofilm formation,
induced defense responses in plants, their insecticidal activity and anti-proliferation
effects on human cancer cell-lines. To further validate their status of potential bioactive
substances, we assessed the results of 775 biological tests on 51 Ps-CLPs available
from literature. From this, a fragmented view emerges. Taken as a group, Ps-CLPs
present a broad activity profile. However, reports on individual Ps-CLPs are often much
more limited in the scope of organisms that are challenged or activities that are explored.
As a result, our analysis shows that the available data is currently too sparse to allow
biological function to be correlated to a particular group of Ps-CLPs. Consequently,
certain generalizations that appear in literature with respect to the biological activities
of Ps-CLPs should be nuanced. This notwithstanding, the data for the two most
extensively studied Ps-CLPs does indicate they can display activities against various
biological targets. As the discovery of novel Ps-CLPs accelerates, current challenges to
complete and maintain a useful overview of biological activity are discussed.
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INTRODUCTION
Cyclic lipodepsipeptides (CLPs) are secondary metabolites with a broad array of biological
functions. They are produced by non-ribosomal peptide synthetases (NRPSs) in bacteria, mostly
Pseudomonas, Bacillus, and Streptomyces spp. (Raaijmakers et al., 2010). Interest in CLPs is
primarily driven by two projected applications: combating multi-drug resistant pathogens in
a clinical setting and use as agents for plant biocontrol and biostimulation in agriculture.
The first is illustrated by daptomycin (Cubicin R©), a CLP produced by Streptomyces spp.
which is FDA-approved for the treatment of complicated skin and soft-tissue infections
caused by Gram-positive bacteria (Arbeit et al., 2004). The second one is exemplified by
the fact that several CLP-producing bacteria, including Pseudomonas spp., are registered with
the United States Environmental Protection Agency (EPA) for biocontrol of plant diseases
linked to CLP metabolite production (Olorunleke et al., 2015b) illustrating their potential
in agriculture. However, the functional role and activity profile of CLPs is considerably
broader (Raaijmakers et al., 2010) and continues to expand, notably with the more
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recent discovery of insecticidal and anti-carcinogenic activities
(Saini et al., 2008; Jang et al., 2013; Cautain et al., 2015). Thus this
class of compounds appears as molecular “Swiss-Army” knives,
capable of demonstrating a variety of biological and functional
effects for the producing organism.
From a chemical point of view, CLPs isolated from
Pseudomonas spp. show a much larger structural diversity
than Bacillus spp. CLPs where only three structurally quite
similar groups have been described (surfactins, iturins, and
fengycins) (Raaijmakers et al., 2010; Meena and Kanwar, 2015).
The variations in overall sequence length, macrocycle length,
amino acid composition, and stereochemistry should in principle
offer possibilities to relate their observed function to (primary)
structure. Once available such structure-function understanding
should promise a better appreciation of these metabolic products
and their underlying biological mechanisms.
Efforts have already been made to catalog CLP primary
structures and their producing organisms, such as the NORINE
database (Caboche et al., 2008). However, the access to biological
activity data is less well, if at all, developed. Review papers of
relevant literature, such as that by Raaijmakers et al. (2010) for
Pseudomonas CLPs, currently remain the single most important
source of information in this respect. As a first step toward a
more structured overview, we review the biological activity of
Pseudomonas spp. CLPs to provide the research community with
a recent body of information and facilitate access to the primary
literature on Ps-CLPs using an overview organized in tabular
format. We specifically focus on the biological activity of CLPs
originating from Pseudomonas spp. (Ps-CLPs) as other reviews
are available that cover those of other organisms in considerable
detail (Perez-Garcia et al., 2011; Cochrane and Vederas, 2016;
Kleijn and Martin, 2017). Moreover, we only considered the data
from tests that were performed using purified Ps-CLPs, excluding
those using medium or cell extracts. The collected biological data,
consisting of 775 reported activities for 51 Ps-CLPs is used to
analyze to what extent the comparison of biological activities
can already be performed and examine certain generalizations
that have been made in the past. Both are preceded by a short
overview and description of Ps-CLPs, while results pertaining to
the mechanism of action are mentioned for completeness but
not exhaustively covered. Rather, the focus lies on extracting
recommendations as to possible steps to be made in order
to improve prospect for structure-function analysis and future
compound application and development.
Pseudomonas spp. PRODUCE A LARGE
VARIETY OF CLPs
Pseudomonas spp. are cosmopolitan organisms found in a
multitude of habitats including soil, organic matter, water, the
rhizosphere, plants and animals, including mammals. The vast
array of metabolites produced includes CLPs of which close
to 100 have been individually documented to varying extent.
Like for Bacillus CLPs, one defining property that Ps-CLPs
have in common, due to the presence of a fatty acid tail,
is their surface tension lowering properties, designating them
as biosurfactants (Fechtner et al., 2011). As more Ps-CLPs
were isolated, specific families or “groups” were defined with
chemically similar Ps-CLPs and named for a particular prototype
Ps-CLP as shown in Figure 1. These include the viscosin (Groupé
et al., 1951), orfamide (Gross et al., 2007; Ma et al., 2016a),
amphisin (Sorensen et al., 2001), syringomycin (Segre et al.,
1989), syringopeptin (Ballio et al., 1991), and tolaasin groups
(Rainey et al., 1991; Bassarello et al., 2004). New CLPs are
continuously found in numerous environments, and can be
assigned to an existing group (D’Aes et al., 2014; Weisshoff et al.,
2014; Johnston et al., 2015; Michelsen et al., 2015a; Zachow
et al., 2015; Ma et al., 2016a; Gotze et al., 2017) or constitute
a new group, such as the recently discovered bananamides,
(Nguyen et al., 2016) and xantholysins (Li et al., 2013). Finally,
a variety of Ps-CLP have not yet formally been classified as a
group (Figure 1) but can be treated as such, if the oligopeptide
length is used as criterion. These include the entolysins (Vallet-
Gely et al., 2010), putisolvins (Kuiper et al., 2003), pseudofactins
(Janek et al., 2010), syringopeptins (Ballio et al., 1991), corpeptin
(Emanuele et al., 1998), and fuscopeptins (Ballio et al., 1996).
With about 100 unique Ps-CLPs distributed over 14 groups
characterized so far, the chance for rediscovery is obviously
increasing, yet the expectation is that not all Ps-CLP groups
have been uncovered so far (Nguyen et al., 2016). With so
many unique Ps-CLP described and to avoid confusion, we will
indicate the individual CLP group members with the first letter
of the group name between brackets, unless the CLP name
is the same as the group name. For example, WLIP, a CLP
of the viscosin group will be designated as WLIP-(V), while
tensin, a CLP of the amphisin group will be denominated as
tensin-(A).
Cyclic lipodepsipeptides are produced by NRPSs, protein
complexes consisting of large multi-domain modules. Current
understanding of the processes involved is well developed, as
collected in the excellent review from Süssmuth and Mainz
(2017). Additionally, Roongsawang et al. (2010) reported a clear
summary on the genomics of the NRPS of Pseudomonas spp. per
lipopeptide-producer. Often, a single biosynthetic NRPS cluster
produces more than one CLP due to an assumed flexibility of
some adenylation domains that are responsible for amino acid
recognition. This results in the production of so-called minors
that differ in the identity of a single amino acid, in addition to
the major compound. It is unclear whether the minors represent
a functional role.
Most likely, CLP production by bacteria is most relevant
in competitive interactions with other coexisting bacteria,
fungi, and oomycetes as well as during interactions with
protozoan predators thus explaining their antimicrobial nature.
In contrast, other activities appear to be unintentional but
potentially beneficial side-effects. Indeed, it seems unlikely
that in their natural habitats CLP-producing bacteria are
affected by viruses (Raaijmakers et al., 2010). A similar
reasoning applies for the anticancer activities that were reported
more recently for several CLPs. In what follows, we chose
to review the biological activity of Ps-CLPs according to
the type of organism that was used to assess a possible
biological effect, rather than by group of CLPs. However, a
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FIGURE 1 | Amino acid sequences of the parent compounds used as basis for Ps-CLP group names. L-amino acids are indicated in blue, while D- and D-allo amino
acids are indicated in green and orange, respectively. Amino acids with unknown stereochemistry are indicated in white.
table correlating biological activity vs. CLP collected in the
process also allows for this alternative view (Supplementary
Material).
Activity Against Bacteria
Cyclic lipodepsipeptides display clear antagonistic activities
against Gram-positive bacteria. Syringopeptin 22A,
syringopeptin 25A, corpeptin-(SP), tolaasin, and WLIP-(V) all
inhibit growth of Bacillus megaterium at similar concentrations
(Emanuele et al., 1998; Grgurina et al., 2002; Bassarello et al.,
2004; Rokni-Zadeh et al., 2012) while conflicting activities
have been reported for syringomycin E and syringotoxin-(SM)
(Lavermicocca et al., 1997; Scaloni et al., 2004). However, early
reports of the biological activity of syringomycin Ps-CLPs
were possibly performed with impure preparations that likely
contained syringopeptins. Generally, syringopeptins have a
higher activity than syringomycins and syringotoxins-(SM)
against Rhodococcus and Micrococcus species (Lavermicocca
et al., 1997).
The CLPs of the structurally quite distinct viscosin
and syringopeptin group possess an antagonistic activity
against several Staphylococcus aureus subspecies, including
methicillin-susceptible and methicillin-resistant strains. Only
WLIP-(V) (D-aIle4, D-Leu5) and massetolide A-(V) (D-Val4,
L-Leu5) lacked activity against all of the tested S. aureus strains
(Gerard et al., 1997; Grgurina et al., 2005; Andolfi et al., 2008;
Reybroeck et al., 2014; Geudens et al., 2017).
The role of metal ions, mostly Ca2+, is often considered
when assessing antimicrobial activity. For instance, the CLP
daptomycin from Streptomyces spp. requires the presence
of calcium ions in order to exert its biological function
(Taylor and Palmer, 2016). More specifically, in complex with
Ca2+, daptomycin forms pore-like oligomers on the bacterial
cytoplasmic membrane, leading to leakage of intracellular
ions, followed by rapid cell death. However, the antibacterial
properties of massetolide A-(V), orfamide A, arthrofactin-(A),
syringomycin E, and entolysin B are found to be independent
of the presence of calcium (Reder-Christ et al., 2012). The
antibacterial activity of pseudofactin II was reported to increase
in the presence of physiological concentrations of various metal
ions including Ca2+, Mg2+, Zn2+, and Cu2+ (Figure 2), but
the underlying working mechanism remains unclear (Janek et al.,
2016).
The vast majority of Ps-CLPs is reported not to show
antagonistic activities against Gram-negative bacteria
(Lavermicocca et al., 1997; Grgurina et al., 2005; Lo Cantore
et al., 2006; Andolfi et al., 2008; Sinnaeve et al., 2009a,b;
Reybroeck et al., 2014). As a result, Pseudomonas CLPs tend to
be considered ineffective against Gram-negative bacteria. This
is generally attributed to the presence of the outer membrane
or peptidoglycan layer which hinders access to the plasma
membrane (Nybroe and Sørensen, 2004; Raaijmakers et al.,
2006). However, things are not as clear-cut since CLPs of the
tolaasin group (Lo Cantore et al., 2006) and the recently described
xantholysin group (Li et al., 2013; Molina-Santiago et al., 2015)
are able to inhibit Gram-negative bacteria. Furthermore,
WLIP-(V) showed a modest activity against the Gram-negative
Erwinia carotovora subsp. carotovora (Lo Cantore et al., 2006).
To add to the apparent confusion, conflicting activities have been
reported against some Xanthomonas species, whereby WLIP-(V)
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FIGURE 2 | Fluorescence microscopy of antagonistic activity of pseudofactin II against Staphylococcus epidermidis KCTC 1917 bacterial cells. The cells are labeled
with a bacterial-viability dye, in which viable cells are green and dead cells are red. Figure reprinted from Janek et al. (2016) with permission.
did (Rokni-Zadeh et al., 2012) or did not (Lo Cantore et al., 2006;
Andolfi et al., 2008) show activity against this Gram-negative
bacterium. This notwithstanding, it is clear that the activity of
Ps-CLPs should not be considered as limited to Gram-positive
bacteria.
Bacterial Mobility
In addition to the antagonistic effects against bacteria that were
described above, Ps-CLPs are also involved in controlling the
motion of their producers. Mobility can occur by a range of
mechanisms including swarming, swimming, twitching, gliding
and sliding (Kearns, 2010). Swarming often depends on the
reduction of the critical surface tension of liquids (Xu et al.,
2012). In this respect, secretion of biosurfactants such as CLPs
potentially reduces the drag of bacterial cells during swarming,
facilitating lateral movement across the surface (Deziel, 2003).
Most of the CLPs produced by Pseudomonas spp. are able to
reduce the surface tension of growth media to different extents
(Fechtner et al., 2011). A minimal threshold surface tension of
24.16 mN m−1 was calculated for Pseudomonas bacteria, based
on a diverse set of surface tension reducing isolates (Fechtner
et al., 2011; Mohammed et al., 2015). This threshold is likely
set by limits in, among others, biosynthesis and transport of
surfactants out of the bacterial cell. For comparison, Triton X100,
often used as laboratory detergent reduces the surface tension to
30 mN m−1. Arthrofactin-(A) appears to be the most powerful
biosurfactant, lowering the surface tension to 24.1 mN m−1
at a CMC of 7.4 µmol L−1 (Morikawa et al., 1993). Ps-CLPs
with much longer peptide chains have a much higher CMC
and cause a smaller reduction in surface tension. For example,
tolaasin and syringopeptin 22A reduce the surface tension to
38 mN m−1 and 40 mN m−1 at CMCs of 211 and 433 µmol L−1,
respectively (Hutchinson and Johnstone, 1993; Hutchinson et al.,
1995; Roongsawang et al., 2010).
Several studies have focussed on Ps-CLPs and their
involvement in surface motility of the producing Pseudomonas
strains either on semi-solid agar (Andersen et al., 2003;
Roongsawang et al., 2003; De Bruijn et al., 2007, 2008; D’Aes
et al., 2010, 2014) or in their natural habitats (Hildebrand
et al., 1998; Nielsen et al., 2005; Tran et al., 2007; Alsohim
et al., 2014). By using CLP-deficient mutants, their role in
the motility of Pseudomonas species was analyzed. In most
cases, surface motility on semi-solid agar plates was lost for the
CLP-deficient mutants, while parent strains did show motility
(Table 1). Generally, motility is restored when endogenous
lipopeptides are added externally to the growth medium
used for Ps-CLP deficient species, conclusively showing that
lipopeptide-production is responsible for bacterial motility.
Interestingly, for an amphisin-deficient mutant of Pseudomonas
sp. DSS73, addition of structurally related [amphisin, tensin-(A),
viscosinamide-(V)] biosurfactants from other Pseudomonas
strains also restored bacterial motility while biosurfactants
from unrelated species, for instance serrawettin from Serratia
marcescens, did not (Andersen et al., 2003). Also, synthetic
surfactants (NP40 and Triton X-100) failed to restore the
motility on semi-solid agar plates. Together this indicates that
reduction in surface tension by itself is insufficient and that other
physical-chemical properties of the biosurfactants are crucial for
surface motility.
When the Pseudomonas tolaasii (producing tolaasin) is
exposed to P. ‘reactans’ LMG 5329 on agar, the formation of a
white line precipitate is observed, a feature that was subsequently
attributed to the White Line Inducing Principle (WLIP), a
Ps-CLP from the viscosin group produced by P. ‘reactans’
LMG 5329. Interaction is accompanied by a reduced surface
motility of its parent Pseudomonas strain. While originally
attributed to WLIP-(V) only, a white line reaction involving
tolaasins [or sessilins-(T)] can also occur with orfamides (D’Aes
et al., 2014; Henkels et al., 2014). CLPs which are more
closely related to WLIP such as viscosin and massetolide-(V)
do not appear to trigger such a reaction, indicating a
structure-dependent interaction between the two CLPs (Rokni-
Zadeh et al., 2013). It was described that Pseudomonas sp.
CMR12a, which produces both sessilins-(T) and orfamides,
is static while the sessilin-deficient mutant is able to swarm
(Figure 3). This swarming, most likely enabled by orfamide
production, is inhibited by the addition of sessilin producers.
However, the interaction dynamics has additional complexity
since adding sessilin containing supernatant did not block the
motility (D’Aes et al., 2014; Olorunleke et al., 2017).
Fungi and Oomycetes
A large body of research has focussed on the antifungal
and anti-oomycete properties of CLPs. Orfamide A,
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TABLE 1 | Overview of swarming properties of lipodepsipeptide-producing Pseudomonas bacteria and their deficient mutants.





P. sp. SBW25 Viscosin Yes Lost Restored De Bruijn et al., 2007; Alsohim
et al., 2014
P. sp. DR54 Viscosinamide-(V) Yes N.D. N.D. Nielsen et al., 2002
P. putida RW10S2 WLIP-(V) Yes Lost N.D. Rokni-Zadeh et al., 2012
P. sp. SS101 Massetolide-(V) Yes Lost N.D. De Bruijn et al., 2008
P. fluorescens Pf-5 Orfamide A Yes Lost Restored Gross et al., 2007; D’Aes et al.,
2014; Ma et al., 2016a
P. fluorescens Orfamide A yes Lost Restored Flury et al., 2017
P. poae RE∗1-1-14 Poaeamide-(O) Yes Lost N.D. Zachow et al., 2015
P. sp. DSS73 Amphisin Yes Lost Restored Koch et al., 2002; Andersen
et al., 2003
P. fluorescens HKI0770 Anikasin-(A) Yes Lost N.D. Klapper et al., 2016; Gotze
et al., 2017
P. sp. MIS38 Artrofactin-(A) Yes Lost Reduced Roongsawang et al., 2003
P. sp. PCL1445 Putisolvin Yes Reduced N.D. Kuiper et al., 2003
P. syringae pv. tomato DC3000 Syringafactin Yes Lost Restored Berti et al., 2007; Burch et al.,
2012
P. entomophila Entolysin Yes Lost N.D. Vallet-Gely et al., 2010
P. putida BW11M1 Xantholysin Yes Lost N.D. Li et al., 2013
P. tolaasii Tolaasin No No N.D. Henkels et al., 2014
P. sp. CMR12c Sessilin-(T) No No N.D. D’Aes et al., 2010
FIGURE 3 | Bacterial swarming of Pseudomonas sp. CMR12a on 0.6% SSM agar plates, and that of mutants deficient in sessilin-(T) (CLP1), orfamide (CLP2), or
sessilin+orfamide (CLP1+CLP2) production. Figure reprinted from D’Aes et al. (2014) with permission.
nunapeptin-(SP) or sessilin-(T) had little or no detectable
effect on the growth or morphology of hyphae of Rhizoctonia
solani while for viscosinamide-(V), pseudophomin-(V),
tensin-(A), pseudomycin-(SM), the tolaasins, entolysin, and
nunamycin-(SM) growth inhibition was clearly observed
(Harrison et al., 1991; Hansen et al., 2000; Nielsen et al., 2000;
Pedras et al., 2003; Bassarello et al., 2004; Gross et al., 2007;
Kruijt et al., 2009; Michelsen et al., 2015b; Ma et al., 2016a).
Remarkably, co-production of orfamide A and sessilin-(T)
by Pseudomonas sp. CMR12a did inhibit growth of R. solani
whereas individually, they did not (Olorunleke et al., 2015a). The
pseudophomins-(V), the pseudomycins-(SM), and WLIP-(V)
all displayed antifungal activity against the phytopathogens
Sclerotinia sclerotiorum and Phoma lingam (Pedras et al., 2003;
Lo Cantore et al., 2006). Syringomycin E inhibited growth
of the postharvest green mold of citrus fruits (Penicillium
digitatum) (Bull et al., 1998). In addition, this lipopeptide showed
antagonistic activities against the human-pathogenic fungi
Aspergillus flavus, A. niger, A. fumigatus, Fusarium moniliforme,
and F. oxysporum (De Lucca et al., 1999). Finally, WLIP-(V),
putisolvin, syringotoxin-(SM), syringopeptin 22A, syringopeptin
25A, and syringomycin E and tolaasin all inhibit the fungal
pathogen Botrytis cinerea with different potencies (Grgurina
et al., 2005; Andolfi et al., 2008; Kruijt et al., 2009).
In the presence of purified viscosinamide-(V), R. solani
showed stunted growth, increased branching and hyphal swelling
(Figure 4; Raaijmakers et al., 2010). Viscosinamide A-(V) has a
similar effect on Pythium ultimum. Also, Pseudomonas species
producing viscosin, poaeamide-(O), amphisin, lokisin-(A),
tensin-(A), syringomycin E, and sessilin-(T) were reported to
inhibit mycelial growth of P. ultimum or Phytophthora infestans
oomycetes in vitro (Nielsen et al., 2000, 2002; Naseby et al., 2001;
Andersen et al., 2003; De Bruijn et al., 2007; Van De Mortel
et al., 2009; D’Aes et al., 2014; Zachow et al., 2015; Kawasaki
et al., 2016) while production of entolysin is not correlated
with biocontrol activity of P. ultimum (Vallet-Gely et al., 2010).
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FIGURE 4 | Cell walls and septa of R. solani stained with Calcofluor white. (A) Untreated fungus shows straight hyphae with only few branches. (B) Treatment with
viscosinamide lead to appearance of highly branched hyphae. Figure reprinted from Raaijmakers et al. (2010) with permission.
Massetolide A-(V) was found to inhibit mycelial growth of
P. infestans but not of P. ultimum (Mazzola et al., 2007; De Bruijn
et al., 2008).
Several experiments addressing protection from fungi in
planta with Pseudomonas spp. have been described in literature
as well. The viscosinamide-producing P. fluorescens DR54
caused an increased plant emergence of sugar beet from
P. ultimum-challenged seeds, although the levels of the control
experiments were not reached (Nielsen et al., 1998). No
increase in root length was observed for non-challenged
seeds in the presence of P. fluorescens DR54. Similarly,
massetolide-producing P. fluorescens SS101 prevents and reduces
infection of tomato leaves by P. infestans. A CLP-deficient
mutant was significantly less effective in biocontrol, while
purified massetolide A-(V) displayed significant control of the
pathogen (Tran et al., 2007). Similar results were obtained with
P. fluorescens SBW25 and its viscosin-deficient mutants.
The yeast-like fungi Cryptococcus neoformans and Candida
albicans were found to be inhibited by tolaasin (Andolfi
et al., 2008), anikasin-(A) (Gotze et al., 2017), and the
pseudomycins-(SM) (Harrison et al., 1991) but not by viscosin
(Geudens et al., 2017) or some of its group members
including WLIP (Lo Cantore et al., 2006; Andolfi et al.,
2008), pseudodesmin A (Sinnaeve et al., 2009b), viscosinamide
(Geudens et al., 2017) or by pseudofactin II (Janek et al.,
2012) or syringopeptin 22A (Grgurina et al., 2005). Finally,
thanamycin-(SM), featuring the exceptionally rare occurrence of
hydroxylation at the Orn2 Cα, is 32 times more potent compared
to the related syringomycin E (Johnston et al., 2015).
Although interesting antifungal properties have mostly
emerged from work relating to crop protection and biocontrol,
they could also present an important therapeutic relevance
as antifungal drugs. Unfortunately, purified Ps-CLPs can be
haemolytic, such as reported for massetolide A-(V) (Van De
Mortel et al., 2009), WLIP-(V) (Andolfi et al., 2008), orfamide
A (Henkels et al., 2014), arthrofactin (Morikawa et al., 1993),
tolaasins (Rainey et al., 1991), syringomycin E (Agner et al.,
2000), and syringopeptins 22A-B (Hutchinson and Gross, 1997).
Despite this, a single injection of 10 mg kg−1 of massetolide
A was reported to be non-toxic to mice (Gerard et al., 1997).
Pseudomycin B, a CLP of the syringomycin group, is effective
against pathogenic fungi in mice and rats, but causes irritation
and eventually necrosis of the affected tissues (Sun et al., 2001).
A series of pseudomycin analogs or prodrugs were obtained
by derivatization of the natural compound. These compounds
retained antifungal effects in vitro and in vivo, but show less
toxicity to experimental animals (Chen et al., 2000; Jamison et al.,
2000; Sun et al., 2001; Zhang et al., 2001a,b). These analogs and
prodrugs are now patented by Eli Lilly and Company (Chen et al.,
2001; Kulanthaivel et al., 2003).
Protozoa
Several secondary metabolites, for example lipodepsipeptides
produced by rhizobacteria, are able to provide protection
against grazing by different protozoan species. The presence
of certain Ps-CLPs can lead to lysis of various protozoa,
as shown for viscosin (Burke et al., 1999), viscosinamide A
(Andersen and Winding, 2004; Pedersen et al., 2011), amphisin
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(Pedersen et al., 2011), anikasin-(A) (Gotze et al., 2017), and
syringomycins (Takemoto et al., 2001).
The ability to lyse protozoan predators represents an
important natural function for lipopeptides: soil populations
of CLP-deficient Pseudomonas strains are compromised in
the presence of protozoa compared to that of soils with the
CLP-producing parental strains (Mazzola et al., 2009). Moreover,
exposure of massetolide-(V) producing P. fluorescens SS101
or viscosin-producing P. fluorescens SBW25 to N. americana
resulted in twofold upregulation of genes involved in CLP
biosynthesis (Mazzola et al., 2009; Song et al., 2015). This
suggests that bacteria can modulate the production of secondary
metabolites in response to protozoan predators. Possibly, this
constitutes a defense mechanism for bacterial strains when
confronted with protozoa.
Insects
Cyclic lipodepsipeptide-producing Pseudomonas spp. are mostly
analyzed for their ability to inhibit bacterial, fungal or protozoan
growth. However, insecticidal properties have also been observed.
Strong insecticidal activity seems to be correlated with the
production of the P. fluorescens insecticidal toxin (Fit), a
sensor protein responsible for the detection of the host
environment (Pechy-Tarr et al., 2013; Ruffner et al., 2013).
It activates insecticidal toxin production specifically upon
infection of the insect host but not while on plant roots
or in standard laboratory media (Pechy-Tarr et al., 2013;
Kupferschmied et al., 2014). However, the toxin is not the
unique killing factor as mutants lacking the Fit genes still
caused a substantial mortality (Ruffner et al., 2013; Rangel
et al., 2016). The insecticidal activity of Pseudomonas species
appears highly multifactorial whereby multiple antimicrobial
compounds, including CLPs, contribute to the oral insecticidal
activity (Keel, 2016; Loper et al., 2016; Flury et al., 2017;
Lim et al., 2017). Using mutant bacterial strains deficient in
CLP production, it was determined that orfamide A and B,
and sessilin-(T) all contribute to the (oral) insect toxicity
exhibited by their producer strains. When applied topically,
a dose-dependent mortality was also observed for purified
orfamide A against aphids (Myzus persicae) (Jang et al., 2013).
Additionally, insecticidal activity against aphids has also been
reported for viscosin (Kupferschmied et al., 2013). Remarkably,
whereas the entolysin-producing P. entomophila is able to infect
and kill Drosophila melanogaster upon ingestion, entolysin itself
was reported not to participate in its virulence (Vallet-Gely et al.,
2010).
Viruses
There is very little information available about the possible role in
nature of the antiviral activity of CLPs, mostly because there is no
clear link between the natural habitat of CLP-producing bacteria
and the presence of viruses. As a result, data on antiviral activity
of Ps-CLPs appears quite sparse. Nevertheless, the very first report
on the lipodepsipeptide viscosin in 1951 already mentioned the
inhibition and inactivation of human pathogenic viruses such as
the infectious bronchitis virus, influenza A virus, and Newcastle
disease virus (Groupé et al., 1951). Recently, Shimura et al. (2013)
described the antiviral activity of the xantholysin-like lipopeptide
MA026 against Hepatitis C.
Impact of Ps-CLPs on Plants
Pseudomonas are often found colonizing the rhizosphere, where
they can either be pathogenic or beneficial for plant growth.
Thus, it is not surprising that many investigations have focussed
on their plant potential for biocontrol or biostimulation.
Considerable data exists that indicates a direct or indirect role
of Ps-CLPs in this respect. Experiments performed in planta
for P. fluorescence SBW25 and its viscosin-deficient mutant
showed that sugar beet or pea seedlings did not display different
germination or development when pre-soaked in water, wild-
type or mutant bacterial solutions, demonstrating that viscosin
alone does not promote plant growth (Naseby et al., 2001;
Alsohim et al., 2014). Similar observation have been made
for massetolide A-(V) (Tran et al., 2007; Cheng et al., 2017).
However, some CLPs are involved in the virulence of certain plant
pathogens, although it is believed that they only contribute to the
colonization of the plants, rather than participate in the virulence
itself. For example, viscosin production is required for the
plant-pathogenic P. fluorescens 5064 to spread to adjacent non-
wounded broccoli florets (Hildebrand et al., 1998). Additionally,
while plant infection of P. syringae pv. syringae still occurs in
the absence of syringomycin or syringopeptin, disease severity
increases drastically when these CLPs are also present (Scholtz-
Schroeder et al., 2001).
Plant biocontrol relies partly on the production of
lipodepsipeptides since these molecules exert their antagonistic
effects against soil borne pathogens. Many different Pseudomonas
spp. can be isolated from the rhizosphere of plants, where they
are able to form biofilms on the root surfaces. For example,
green fluorescent protein (gfp) labeled Pseudomonas sp. DR54,
which produces viscosinamide A-(V), is found in the rhizosphere
(rhizoplane) of barley roots (Figure 5A), forming mixed
micro-colonies together with the indigenous bacteria located
near the crevices of epithelial cells of the roots (Normander
et al., 1999). Additionally, there is evidence that CLPs are able
to induce systemic resistance (ISR) in plants, providing an
additional defensive effect against physically separated pathogens
(Figure 5B). ISR involves the stimulation of the immune systems
in plants and is an alternate mechanism by which Pseudomonas
spp. can induce biocontrol against fungi and oomycetes (Tran
et al., 2007; Ma et al., 2016b).
Biofilms
Cyclic lipodepsipeptides have also been implied in the regulation
of biofilms and thus hold potential for biomedical applications,
for instance as part of coatings that prevent biofilm formation.
Thus, considerable literature relating to the effect of Ps-CLPs
on biofilms is also available. For Bacillus and Pseudomonas
spp., CLPs play an important role in surface attachment and
biofilm formation, although the outcome depends on the type
of CLP (Raaijmakers et al., 2010). Massetolide A-(V) (De
Bruijn et al., 2008), sessilin-(T) (D’Aes et al., 2014), and
xantholysin (Li et al., 2013) support their producers in the
formation of biofilms, whereas viscosin (Bonnichsen et al., 2015),
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FIGURE 5 | (A) Localization of gfp-Pseudomonas sp. DR54 (green cells) and indigenous bacteria (blue cells) in the rhizosphere (rhizoplane) of barley roots. Mixed
micro-colonies are indicated by arrows A and B. Epithelial cells are indicated with arrows C and D. Figure modified from Normander et al. (1999); (B) Schematic of
the biocontrol mechanisms of CLPs, including induced systemic resistance. Figure reprinted from Vlamakis et al. (2013) with permission.
WLIP (Rokni-Zadeh et al., 2012), orfamide B (D’Aes et al.,
2014), arthrofactin (Roongsawang et al., 2003), and putisolvin I/II
(Kuiper et al., 2003; Kruijt et al., 2009) appear to inhibit biofilm
formation of their producing strains. Additionally, entolysin
(Vallet-Gely et al., 2010) does not appear to be involved in
the formation or breakdown of biofilms, although it should
be mentioned that no detailed time-resolved experiment was
performed, possibly explaining this apparent difference.
Initially, a single time-point analysis showed that viscosin
is involved in the formation of biofilms by Pseudomonas sp.
SBW25, since its viscosin-deficient mutants were unable to form
biofilms on an artificial surface. Supplementing the mutant’s
growth medium with purified viscosin restored biofilm formation
(De Bruijn et al., 2007). However, in a subsequent time-resolved
study (Bonnichsen et al., 2015) it was shown that biofilms of
a viscosin-deficient mutant and its wild-type P. sp. SBW25
developed comparably during the first 11.5 h. Subsequently,
a significant difference emerged as the amount of P. SBW25
associated biofilm decreased, whereas the mutant continued to
develop biofilm throughout the period. Thus, over time, the
viscosin-deficient mutant forms more biofilm than the wild-
type in long-term incubations, in contrast with what was found
earlier (De Bruijn et al., 2007). The authors attributed this to
the temporal dynamics of biofilm formation and dispersal. When
dispersal of biofilms was induced through carbon starvation,
a viscosin-deficient mutant dispersed to a lesser extent than
the wild-type. Notably, carbon starvation did partially induce
viscosin biosynthesis gene expression in the wild-type, followed
by biofilm dispersal. The dispersal mechanism is of vital
importance as it allows bacteria to escape from unfavorable
nutrient conditions and spread throughout the environment to
colonize new areas.
Given the variable and sometimes contradictory effects in
biofilm regulation noted to date from only a handful of
Ps-CLPs, the underlying mechanisms in biofilm formation and
development can only be speculated upon. It is possibly related
to the differing physicochemical properties and to the potential
effect of CLPs on the cell surface and/or substrate (Neu, 1996;
Raaijmakers et al., 2010). Indeed, hydrophobic interactions and
surface-active compounds, including CLPs, have been suggested
to play a role in the adherence of cells to surfaces (De Bruijn et al.,
2008). For instance, whereas pseudofactin II did not present any
antifungal activity against C. albicans, it did show a marked ability
to reduce adhesion and biofilm formation of this pathogen on
catheters or polystyrene surfaces pre-incubated with solutions of
pseudofactin II above its critical micelle concentration. Similar
results were obtained for Staphylococcus aureus, S. epidermidis
and Streptococcus agalactiae. In addition, pseudofactin II is able to
disperse preformed biofilms of all these pathogens (Biniarz et al.,
2015; Janek et al., 2016).
Anti-proliferative Activities of Ps-CLPs
Another domain which is opening up to Ps-CLPs is that of
cancer research. For example, it was observed that viscosin
inhibits migrations of a breast cancer cell line (MDA-MD-231)
and a metastatic prostate cancer cell line (PC-3M) without
causing toxicity (Saini et al., 2008). Pseudofactin II was reported
to induce apoptosis of human melanoma cells while normal
human dermal fibroblast cells, used as a control, were less
affected (Janek et al., 2013). The authors hypothesized that
apoptosis might be induced by interaction of lipopeptide
micelles with the plasma membrane, leading to membrane
permeabilization.
When various cancer cell lines (T-cells leukemia, mantle cell
lymphoma, and melanoma cell lines) were treated with a mixture
of the syringomycin-group CLP nunamycin and nunapeptin, a
syringopeptin group member, apoptosis ensued while treatment
of healthy cells in the same concentration range had no effect.
After treatment with the CLP mixture, the majority of the
leukemia T-cells seemed to be in the early apoptotic state.
Treatment with either Ps-CLP alone did not prompt apoptosis
(Michelsen et al., 2015a).
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The major lipopeptide isolated from Pseudomonas soli sp.
nov., identified as xantholysin A, and MDN-0066, isolated from
Pseudomonas granadensis F-278,770T showed activity on a kidney
tumor cell line (RCC4) (Pascual et al., 2014; Cautain et al., 2015).
The authors attributed this selective toxicity to an inactivation of
the Von Hippel Lindau (VHL) gene linked to activation of the
hypoxia induced transcription factor (HIF) pathway.
Mechanism of Action of Ps-CLPs
Considerable literature supports or indicates membrane-
perturbation – and in particular pore-formation – as the origin
of antimicrobial activity. This is in line with the amphipathic
character of Ps-CLPs, which enables these peptides to perturb
the barrier function of the membrane. Indeed, several Ps-CLPs
are able to permeabilize model membranes with varying
composition, possibly though formation of transmembrane
pores (Brodey et al., 1991; Cho and Kim, 2003; Lo Cantore
et al., 2006; Andolfi et al., 2008; Geudens et al.). These pores
are thought to collapse the pH gradient across the membrane
by increasing the influx of H+ and Ca2+ ions as well as the
eﬄux of K+ ions (Kozlova et al., 2004; Aiyar et al., 2017).
This ultimately leads to an induction of calcium-mediated
signaling pathways, leading to cell death. However, the precise
events involved in the pore-forming processes of Ps-CLPs and
the exact type of pores remains largely unknown. A variety
of membrane perturbing mechanisms for membrane-active,
often cationic antimicrobial peptides, have been described
and the reader is referred to excellent reviews on this topic
(Brogden, 2005; Melo et al., 2009; Lee et al., 2016; Li et al.,
2017; Kumar et al., 2018). However, the overall bulk of studies
relates to cationic antimicrobial peptides, and few systematic
studies are available for Ps-CLPs. For syringomycin E, a body
of published research indicates a role for fungal sphingolipids
in its antifungal action (Bender et al., 1999; Stock et al., 2000;
Takemoto et al., 2003; Kaulin et al., 2005). More specifically, the
presence of sphingolipids with natural (C4-hydroxylated) long
chain bases are a requisite for the yeast Saccharomyces cerevisiae
to be sensitive in vivo to syringomycin E (Stock et al., 2000;
Kaulin et al., 2005). A yeast mutant having sphingolipids with
a sphingoid base devoid of C4-hydroxylation was found to be
resistant to the lipopeptide. Interestingly, the presence of the
mutant sphingolipid diminished the ability of syringomycin E
pores to open synchronously but it did not alter the single
pore conductance or the gating charge (Kaulin et al., 1998). In
another notable study, five Ps-CLPs from different groups were
investigated for their interactions with bacteria-like lipid model
membranes Reder-Christ et al. (2012). It was proposed that
their membrane incorporation is driven by the initial interaction
of the polar amino acid residues with the polar head groups
of the phospholipids, followed by incorporation of the fatty
acids into the membrane core. Subsequently, the lipopeptide is
assumed to incorporate into the membrane. This incorporation
is reversible, although the dissociation rate constant is low
compared to the association rate (Reder-Christ et al., 2012). In
other work, total synthesis of the enantiomer of pseudodesmin
A, a member of the viscosin group, was used to exclude chiral,
receptor-based interactions as the main determinant of the
biological activity since the enantiomer proved as active as the
natural compound (De Vleeschouwer et al., 2014). Despite these
reports, the detailed molecular events leading to pore-formation,
once individual molecules have been incorporated, and the
exact relation to Ps-CLP sequence and structure remains to be
established. In this respect it was proposed that the self-assembly
of viscosin group Ps-CLPs potentially plays an (indirect) role in
the biological activity of these CLPs, as it could be an import
factor in the creation of pore-like structures through the cellular
membrane (Sinnaeve et al., 2009a; Geudens et al., 2014). Also,
Syringomycins actively involve lipid molecules in the structural
assembly process leading to pore-formation (Malev et al.,
2002; Szabó et al., 2004). It is believed that an asymmetric
lipid pore is formed that is stabilized by peptide molecules
(Malev et al., 2002; Ostroumova et al., 2007a). Therefore, the
presence of different lipids and/or sterols can modulate the
effect of the CLPs (Takemoto et al., 1991; Julmanop et al., 1993;
Wangspa and Takemoto, 1998; Dalla Serra et al., 1999; Coraiola
et al., 2006; Efimova et al., 2016). Additionally, the membrane
dipole potential appears to play a significant role in the pore
forming ability of Ps-CLPs (Ostroumova et al., 2007b, 2008).
Nevertheless, when considering the sequence and structure
of the various Ps-CLP groups in Figure 1, it is unlikely that a
single overall mode of action can be attributed to explain their
bioactivities. For instance, syringomycins are multiply positively
charged lipopeptides, with a predominance of polar, hydrophilic
residues, whereas most others are neutral lipopeptides or feature
a single negative charge while apolar, hydrophobic residues are
prevalent (Figure 1). Starting with tolaasin, the larger Ps-CLPs
display a single positive charge occurs within the macrocycle,
with either a long amphipathic oligopeptide sequence in the case
of tolaasin or a mostly hydrophobic one for the other Ps-CLP
groups characterized by long exocyclic oligopeptide moieties.
Thus, while considerable data is now available, much terrain
remains to be covered. It is hoped that the growing interest in
Ps-CLPs, combined with the biological data reviewed here and
the further development of efficient synthesis route to Ps-CLP
will stimulate detailed biophysical studies into their mechanism
of action.
DISCUSSION
We attempted to exploit the material collected for this review
to gain additional insight into general trends and correlations in
the biological activity of Ps-CLPs (Supplementary Table 1). As
most data pertains to antibacterial and antifungal properties, only
these were analyzed in more detail. In total, 66 literature reports
(Supplementary Figure 1) were used to analyze a total of 775
biological tests, involving 51 CLPs, of which 507 (65%) showed a
clear activity compared to controls. Significantly more tests were
performed against fungi (306; 39%) compared to Gram-positive
(180; 23%) and Gram-negative bacteria (181; 23 %), whereas
more limited testing was described with respect to mycobacteria
(22; 3%) (Figure 6A).
Although Ps-CLPs have been described since the 1950s, it is
only since the mid-1990s that routine testing of the biological
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FIGURE 6 | (A) Distribution of biological tests according to micro-organism type, (B) distribution of all biological tests according to CLP group.
functions of Ps-CLPs started (Supplementary Figure 2). The use
of a particular category of micro-organisms for tests involving
Ps-CLPs does not show any specific trend with time (data not
shown).
Of the 14 Ps-CLP groups that were considered (Figure 1),
the viscosin group is the most studied, being the subject of 39%
of all biological assays (Figure 6B). However, this is mainly
due to the high number of tests performed for WLIP: 160
of the 298 tests for the viscosin group involve this particular
Ps-CLP and overall it represents just over one fifth (20%) of the
assays involving all Ps-CLP reviewed here. Thus, it is the best
characterized Ps-CLP (vide infra). The surprisingly large number
of tests can indicate some bias in the environments sampled but
also reflects the interest in the “White Line” reaction it forms with
the tolaasins (50% of WLIP tests). Indeed, the latter Ps-CLP group
has also been extensively tested (145 tests), representing 19% of
all assays involving Ps-CLP. At the other extreme, four Ps-CLP
groups (the orfamides, amphisins, putisolvins and pseudofactins)
each represent less than 2.5% of all assays. Thus, there is quite
some variation in the extent to which specific the activities of
individual Ps-CLPs have been uncovered. Within each category
of micro-organisms, the distribution of tests per CLP group is
similar to that shown in Figure 6B, although slightly more tests
against Gram-positive bacteria have been performed for viscosin
group Ps-CLPs (Supplementary Figure 3).
Despite the high number of available biological tests, it
is difficult to use these for a comparative overview, let
alone to correlate the absolute and relative activities of
CLPs with certain structural features. Difficulties arise mainly
from the lack of overlap in the micro-organisms used for
testing and from differences in assay types and resulting
quantification of bioactivity using different measures (inhibition
zones, inhibitory concentrations, inhibitory quantities etc.).
As part of their investigation into antibiotic activities of
Pseudomonas lipopeptides using model membrane systems,
Reder-Christ et al. (2012) investigated the antimicrobial activity
of massetolide A-(V), syringomycin E, orfamide A, arthrofactin-
(A), and entolysin B against 16 Gram-positive species over 8
genera and 6 Gram-negative species over 5 genera using a
disk diffusion assay. Of these 110 tests, only 8 proved positive,
all against Gram-positive bacteria, with all CLPs but orfamide
being active against Arthrobacter crystallopoietes DSM 20117,
and only arthrofactin-(A) showing additional activity against
Corynebacterium (3 species) and Mycobacterium smegmatis
ATCC 70084. None of the Ps-CLPs proved active against the
Gram-negative bacteria. The lack of activity appears at odds with
the other literature data reported here. Closer inspection with
other reports of diffusion disk assays shows that the quantities
used for testing (1.5 to 3 µg) are to the low end compared
to those used in other work, which typically ranges from 9 to
50 µg (Grgurina et al., 2005; Li et al., 2013). The concentration
used for such assays, is obviously set by what is considered
to be a useful threshold to indicate weak, medium or strong
antimicrobial activity. As we used a binary grading (vide infra) to
survey activities of Ps-CLPs and the test reported by Reder-Christ
et al. (2012) uses low test concentrations to detect significant
biological activity, we chose not to include their data in the
number presented in our survey.
In the following, we consider the biological activities of
Ps-CLPs against Gram-positive, Gram-negative and fungi in a
binary fashion, where a Ps-CLP is simply active (“Hit”) or inactive
(“Miss”) compared to the control, irrespective of the assay used
(Figure 7 and Supplementary Figure 4).
Not unexpectedly, the initial survey of the data in Figure 7
suggests that mapping of the biological activity spectrum is still
quite fragmented, both in scope and in number. Understandably,
the more limited activity profiling simply reflects the specific
interest of the authors. Nevertheless, some patterns in activity
profiles can be seen.
For the 7 Ps-CLP groups that were tested for their
antifungal properties, activity against 41 different fungal genera
(representing 72 different species) is apparent in 81% of the
tests, indicating a clear antifungal potential throughout the
Ps-CLPs (Figure 7 and Supplementary Table 2). Considering
only those micro-organisms for which the number of tests n
per CLP group equals 3 or more (n ≥ 3) on a genus-level
(e.g., Aspergillus or Fusarium), the Ps-CLPs generally display a
broad activity against fungi (Table 2). In total, 95 biological
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FIGURE 7 | The percentage of hits per activity test against Gram-positive, and Gram-negative bacteria and against fungi for each Ps-CLP group investigated so far.
The numerical data labels above the individual series indicate the total number of tests performed. If all tests are hits, 100% is reached.
tests were used to assess the antifungal properties of viscosin
group Ps-CLPs, of which 65% were positive. Since several genera
did not satisfy our n ≥ 3 test criterion (vide supra), they are
not included in our analysis. However, more extensive tables
are available in the Supplementary Information. Ten different
fungal genera were challenged with viscosin group Ps-CLPs
with n ≥ 3, of which only three were unaffected: Aspergillus
(n = 4), Candida (n = 10), and Cryptococcus (n = 4). The
viscosin group CLPs showed clear activity against Phytophthora
infestans (n = 4), but not against P. citrophthora (n = 2) or
P. nicotianae (n = 2). Another set of ten fungal genera, partly
overlapping with those challenged with viscosin, were exposed
to syringomycin group members, showing activity against all.
No conclusions can currently be drawn regarding the activity of
Ps-CLPs from other groups against Aspergillus or Cryptococcus,
as these were not tested (or n < 3). Ps-CLPs of the syringopeptin
groups also display activity against Candida (n = 8), while
some selectivity seems present for tolaasins (n = 4). Of the
9 fungal genera treated with tolaasins, only Candida showed
some resistance. More specifically, a clear activity was reported
against C. albicans (n = 2), but C. parapsilosis was unaffected
(n = 2).
Five fungal genera were tested against at least three Ps-CLP
groups with excellent antifungal activity, with the exception of the
viscosin group against Candida. All other CLP groups, tested with
2 to 4 fungal genera also showed activity against all tested fungi,
indicating a broad spectrum effect. In addition, the susceptibility
of Gram-positive bacteria against Ps-CLPs already evident from
individual studies appears as an almost generic trait, based on the
data collected here.
More specifically, 180 tests were performed to assess the
activity of Ps-CLPs against 18 different genera (representing
34 species) of which 141 tests were positive (78%) (Figure 7).
The collected data allows to identify 6 Ps-CLP groups where
the number of tests n ≥ 3 on a genus-level involving 11
genera (Table 3). The data shows an almost generic impact on
TABLE 2 | Overview of the number of “hits” compared to the number of tests n reported against fungi per Ps-CLP group.
Syringomycin Viscosin Orfamide Xantholysin Tolaasin Syringopeptin
Agaricus 4 (n = 4)
Aspergillus 7 (n = 10) 0 (n = 4)
Botrytis 3 (n = 3)
Candida 7 (n = 7) 0 (n = 10) 2 (n = 4) 8 (n = 8)
Cryptococcus 7 (n = 7) 0 (n = 4)
Fusarium 4 (n = 6) 5 (n = 5) 6 (n = 6)
Geotrichum 6 (n = 6) 3 (n = 6)
Lentinus 3 (n = 3)
Phoma 3 (n = 3)
Phytophthora 4 (n = 4) 4 (n = 8) 4 (n = 4)
Pleurotus 9 (n = 9) 4 (n = 5)
Pythium 14 (n = 14) 3 (n = 4)
Rhizoctonia 9 (n = 9) 8 (n = 8) 5 (n = 6)
Rhodotorula 7 (n = 10) 19 (n = 23) 6 (n = 6)
Sclerotinia 4 (n = 4) 6 (n = 6)
Magnaporthe 3 (n = 3)
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TABLE 3 | Overview of the number of “hits” compared to the number of tests n reported against Gram-positive bacteria per CLP group.
Syringomycin Viscosin Xantholysin Tolaasin Syringopeptin
Bacillus 4 (n = 6) 12 (n = 15) 3 (n = 3) 11 (n = 12) 13 (n = 13)
Clavibacter 4 (n = 4) 4 (n = 4)
Clostridium 6 (n = 6)
Enterococcus 11 (n = 12)
Micrococcus 2 (n = 3) 2 (n = 4)
Propionibacterium 4 (n = 4)
Rhodococcus 2 (n = 3) 3 (n = 3) 8 (n = 9)
Staphylococcus 15 (n = 30) 8 (n = 12)
Streptococcus 8 (n = 8)
Gram-positive bacteria of the 5 Ps-CLP groups. Bacillus spp. are
found to be strongly affected (88% of the tests on average) by all
Ps-CLPs, while all 9 genera listed are strongly affected by viscosin
group Ps-CLPs. The only exception is Staphylococcus where hits
were observed for ∼50% of all tests. This is also the case for
Micrococcus, although this should be confirmed as n = 4 only.
While for the other 4 Ps-CLP groups biological activities are
reported in a much more focused set of 2 or 3 genera, activity is
present at 90% or more of the tests in all cases. Thus, the data
substantiates a general susceptibility of Gram-positive bacteria
against Ps-CLPs.
As for Gram-negative bacteria, 181 tests were reported against
a panel of in total 19 genera (representing 45 species), of
which 51 tests were “hits” (28%) (Supplementary Table 4).
From all the data (Table 4), 6 Ps-CLP groups can be identified
where the number of tests n ≥ 3 on a genus-level, involving
7 genera (Table 4), with Escherichia and Pseudomonas being
most extensively tested. The lack of activity originally suggested
to exist for Ps-CLPs in the case of Gram-negative bacteria
(Nybroe and Sørensen, 2004; Reder-Christ et al., 2012) should
be nuanced. Although clearly less successful than against Gram-
positive bacteria, the different cell envelope architecture of Gram-
negative bacteria does not provide absolute protection from Ps-
CLPs. A notable difference with Gram-positive bacteria is the
larger selectivity. Indeed, when testing Gram-negative bacteria
none of the 30 tests featuring Ps-CLPs from the syringopeptin
group were positive. In contrast, 16 of the 21 tests (76%) of
xantholysin against Gram-negative bacteria were positive, with
potent effect against Pseudomonas and Xanthomonas, but no
effect against Escherichia. A more in depth analysis learns that
no overlap exists between the collection of species used to test
xantholysin and syringopeptin, respectively, which is necessary
before a generalization can be made. Interestingly, the tolaasins,
which like syringopeptin, are large peptide amphiphiles with
positive charge, do show activity against certain Gram-negative
species which, again, do not overlap with those of the other
two Ps-CLPs. Given the larger selectivity observed here, more
data, against identical species, should be collected before any
generalization can be made. Indeed, it may well turn out that
xantholysins are equally inactive against those used to test the
syringopeptin CLPs, whereas the latter may also be active against
those exposed to xantholysin. More generally, when considering
only those bacteria of which n ≥ 3 per CLP group, conclusions
can solely be made for a limited number of Gram-negative
bacterial genera (Table 4). All tested Ps-CLP groups do not
exhibit activity against Citrobacter, Erwina, Escherichia, Proteus,
or Salmonella genera. In case of Pseudomonas and Xanthomonas
genera, there appears to be a discrimination depending on the
CLP group. Although the xantholysins (n = 12) and the tolaasins
(n = 6) are produced by Pseudomonas spp., they do appear
to have (some) activity against this bacterium. However, both
groups were not tested against the same species. Specifically,
the tolaasins are able to inhibit the growth of P. syringae and
P. corrugata whereas the xantholysins possess activity against
P. aeruginosa, P. putida, P. mendocina, and P. nitroreducens.
Finally, Xanthomonas spp. are not susceptible to syringomycins,
but are to xantholysins (n = 3) and viscosins (n = 16). However,
the latter is exclusively due to results collected for WLIP.
Therefore, rather than stating that viscosins have activity against
Gram-negative bacteria, a more accurate conclusion would be
that WLIP, a CLP of the viscosin group, is active against
Xanthomonas spp.
TABLE 4 | Overview of the number of “hits” and the number of tests n reported against Gram-negative bacteria per CLP group.
Syringomycin Viscosin Putisolvin Tolaasin Xantholysin Syringopeptin
Citrobacter 0 (n = 4)
Erwinia 1 (n = 3) 1 (n = 3) 3 (n = 10)
Escherichia 1 (n = 3) 0 (n = 12) 2 (n = 12) 0 (n = 4) 0 (n = 6)
Proteus 0 (n = 4)
Pseudomonas 1 (n = 5) 0 (n = 21) 0 (n = 4) 6 (n = 11) 11 (n = 12) 0 (n = 8)
Salmonella 0 (n = 5) 0 (n = 4)
Xanthomonas 1 (n = 3) 14 (n = 16) 3 (n = 3)
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From the above, it is clear that comparison of the reported
biological activities of different CLPs in order to assess the effect
of certain structural modification is precluded by the fact that
collections of microorganisms used in the individual studies
are mostly non-overlapping. When attempting to establish a
structure-activity relation for the Ps-CLPs, one has been limited
to the natural variations that occur.
Recently, the biological activities of different natural CLPs
of the viscosin group were assessed, showing that the D/L
stereo-inversion that occurs in the viscosin group does not
have an impact on the antibacterial activities (Geudens et al.,
2017). In contrast, WLIP-(V) and viscosin, containing an
ionisable D-Glu2, generally had a lower activity compared to
their respective D-Gln2 homologs pseudodesmin A-(V) and
viscosinamide A-(V). This finding is thought to be related to an
altered membrane-water partitioning.
Alternatively, chemical peptide synthesis can prove a valuable
tool to establish a structure-function relation of the Ps-CLPs.
For example, using an efficient solid-phase peptide synthesis
approach, the enantiomer of pseudodesmin A, a viscosin group
member, showed identical activity to the parent compound
when confronted with a panel of Gram-positive bacteria (De
Vleeschouwer et al., 2014). Thus, a chiral, receptor based
interaction is not the main determinant of its biological activity
(De Vleeschouwer et al., 2014). Taken together, these findings
already provide an initial insight in the working mechanism of
the Ps-CLPs, and with the availability of efficient synthesis routes
toward Ps-CLPs the generation of chemical structure diversity to
further investigate the structure-activity relationship studies can
be expected.
CONCLUSION
Given the many different biological environments where
Pseudomonas species play a role, they truly are “multi-talented
bacteria” (Keel, 2016) and with exception of Pseudomonas
aeruginosa, their specialized metabolome constitutes a rich
source of amphiphilic CLPs. As a family, Ps-CLPs appear as the
equivalent of a “Swiss-Army knife” capable of a wide range of
biological and functionally relevant effects, using the same overall
molecular blue-print. In addition and even though extensive
biological data only exists for a limited few Ps-CLPs, the data
of WLIP and tolaasin indicate that this multi-tool character
can also be attributed to individual Ps-CLP members. Ps-CLPs
thus appear as a rich source of compounds in fundamental and
application oriented research. The antifungal activity appears to
be the most generally expressed property of Ps-CLP, followed
by activity against Gram-positive bacteria. Antagonistic effects
against Gram-negative bacteria, while present, are clearly more
selective and currently more limited toward specific organisms.
In all cases, however, some or considerable tolerance can be found
against specific genera. Therefore, generalizations regarding the
biological activities of Ps-CLPs should be avoided or presented
with the appropriate context.
In spite of the increasingly large body of activity data,
the large diversity in the handful of organisms selected for
activity assays from one study to another, let alone the diversity
in procedures used and concentration ranges tested, limits
meaningful comparison of the potency of Ps-CLPs or derivation
of structure-activity relationships to a few very specific cases.
In our opinion, this causes considerable hindrance for the
further exploration and development of Ps-CLPs as biological
agents (Geudens et al., 2018). This could be partly addressed
by defining a common series of organisms, reference strains
(i.e., ATCC, NCPPB, BCCM, etc.) cancer-cell lines etc., as
well as assaying procedures and practices that could be made
available to characterize newly isolated Ps-CLPs, irrespective of
the particular interest of the investigating research group. The
data could then be used to annotate existing databases (e.g.,
NORINE) or to develop new ones (Geudens et al., 2018). In this
way, identification of a newly isolated compound as an already
described Ps-CLP would immediately also provide functional
information, while the availability of uniform testing protocols
would immediately allow to relate the functional repertoire of a
novel, previously undescribed compound to the existing library
of information. This is particularly pertinent given the recent
development of metabolite indexing approaches using mass-
spectrometry that promise to accelerate the discovery of new
metabolites compared to the usual one-molecule–one-microbe
at a time approach, as was recently demonstrated for Ps-CLPs
(Nguyen et al., 2016). Only by investing in functional annotation
of metabolites or groups of metabolites – such as Ps-CLPs – using
a priori agreed upon assays, will it be possible to realize the full
scientific potential that they may hold for science and society.
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